2009Chinese Journal of Hospital PharmacyRequires access

Long-term toxicity study of 13-methyltetradecanoic acid in Beagle dogs

Longgang He

Open publisher page 0 citations

Abstract

OBJECTIVE To monitor toxic reactions and seriousness due to long-term accumulation of drug in the body of Beagle dogs after twelve-week oral administration of 13-methyltetradecanoic acid(13-MTD),for reference in clinical trials.METHODS Twelve Beagle dogs were randomly divided into 3 groups of 4 with 2 in each gender.The dogs in two test groups were orally administered with 13-MTD at 0.4 g·kg-1 and 0.8 g·kg-1 daily for twelve weeks,respectively.RESULTS No significant anomalies were found in the animals in test groups,comparing to those in the control group,including electrocardiogram, hemogram,hepatorenal functions,routine examination of urine,and pathological biopsy.Another 2-week observation after the end of treatment also showed no delayed abnormal reactions.CONCLUSION Oral administration of 13-MTD 0.8 g·kg-1(40 times clinically recommended dose) daily for twelve weeks in beagle dogs was safe.

About this research paper

What this paper is about

OBJECTIVE To monitor toxic reactions and seriousness due to long-term accumulation of drug in the body of Beagle dogs after twelve-week oral administration of 13-methyltetradecanoic acid(13-MTD),for reference in clinical trials.METHODS Twelve Beagle dogs were randomly divided into 3 groups of 4 with 2 in each gender.The dogs in two test groups were orally administered with 13-MTD at 0.4 g·kg-1 and 0.8 g·kg-1 daily for twelve weeks,respectively.RESULTS No significant anomalies were found in the animals in test groups,comparing to those in the control group,including electrocardiogram, hemogram,hepatorenal functions,routine examination of urine,and pathological biopsy.Another 2-week observation after the end of treatment also showed no delayed abnormal reactions.CONCLUSION Oral administration of 13-MTD 0.8 g·kg-1(40 times clinically recommended dose) daily for twelve weeks in beagle dogs was safe.

Why it matters

A significance statement is not available in the OpenAlex record.

Key contribution

A contribution statement is not available in the OpenAlex record.

Method / approach

Method details are not available in the OpenAlex metadata.

Main findings

Findings are not separately available in the OpenAlex metadata.

Limitations

Limitations are not available in the OpenAlex metadata.

Applications

Application details are not available in the OpenAlex metadata.

Available abstract

OBJECTIVE To monitor toxic reactions and seriousness due to long-term accumulation of drug in the body of Beagle dogs after twelve-week oral administration of 13-methyltetradecanoic acid(13-MTD),for reference in clinical trials.METHODS Twelve Beagle dogs were randomly divided into 3 groups of 4 with 2 in each gender.The dogs in two test groups were orally administered with 13-MTD at 0.4 g·kg-1 and 0.8 g·kg-1 daily for twelve weeks,respectively.RESULTS No significant anomalies were found in the animals in test groups,comparing to those in the control group,including electrocardiogram, hemogram,hepatorenal functions,routine examination of urine,and pathological biopsy.Another 2-week observation after the end of treatment also showed no delayed abnormal reactions.CONCLUSION Oral administration of 13-MTD 0.8 g·kg-1(40 times clinically recommended dose) daily for twelve weeks in beagle dogs was safe.

Key concepts: Beagle, Medicine, Urine, Oral administration, Internal medicine, Physiology

Related papers

Back to paper searchBrowse research topicsOriginal source
Long-term toxicity study of 13-methyltetradecanoic acid in Beagle dogs — Research Paper | ScholarLens